Edit |   |
---|---|
Product Name | Seralutinib |
Description | A PDGFR, c-Kit, and CSF1R inhibitor; inhibits PDGF-BB-induced phosphorylation of ERK in H1703 cells, HPASMCs, and HLFs (IC50s = 74, 49, and 62 nM, respectively); inhibits stem cell factor-induced c-Kit autophosphorylation in HPAECs and M-CSF-induced CSF1R phosphorylation in human primary differentiated macrophages (IC50s = 7.8 and 14.4 nM, respectively); inhibits the proliferation of H1703 cells and PDGF-BB-induced HPASMCs and HLFs (IC50s = 32, 33, and 29 nM, respectively); prevents increases in pulmonary artery systolic pressure in a rat model of pulmonary arterial hypertension induced by monocrotaline pneumonectomy when administered via passive inhalation at 2.5 mg/kg |
Size | 50 mg |
Concentration | n/a |
Applications | n/a |
Other Names | GB002|PK 10571 |
Gene, Accession, CAS # | CAS: 1619931-27-9 |
Catalog # | 37754-50 |
Price | $728.00 |
Order / More Info | Seralutinib from CAYMAN CHEMICAL COMPANY |
Product Specific References | n/a |